Analysts Offer Insights on Healthcare Companies: Insulet (PODD), Charles River Labs (CRL) and Warby Parker (WRBY)
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Insulet (PODD – Research Report), Charles River Labs (CRL – Research Report) and Warby Parker (WRBY – Research Report).
President's Day Sale - 70% Off
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Insulet (PODD)
Morgan Stanley analyst Patrick Wood maintained a Buy rating on Insulet today and set a price target of $370.00. The company’s shares closed last Friday at $242.00.
According to TipRanks.com, Wood is a 1-star analyst with an average return of
Currently, the analyst consensus on Insulet is a Strong Buy with an average price target of $353.47, implying a 41.9% upside from current levels. In a report released yesterday, TipRanks – DeepSeek also upgraded the stock to Buy with a $285.00 price target.
See Insiders’ Hot Stocks on TipRanks >>
Charles River Labs (CRL)
In a report released today, Kallum Titchmarsh from Morgan Stanley maintained a Hold rating on Charles River Labs, with a price target of $185.00. The company’s shares closed last Friday at $165.50, close to its 52-week low of $150.79.
According to TipRanks.com, Titchmarsh is a 3-star analyst with an average return of
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Charles River Labs with a $207.56 average price target, implying a 26.4% upside from current levels. In a report released today, Mizuho Securities also maintained a Hold rating on the stock with a $175.00 price target.
Warby Parker (WRBY)
In a report released today, Joe Feldman from Telsey Advisory maintained a Buy rating on Warby Parker, with a price target of $32.00. The company’s shares closed last Friday at $23.30.
According to TipRanks.com, Feldman is a 4-star analyst with an average return of
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Warby Parker with a $31.00 average price target, implying a 33.0% upside from current levels. In a report released today, Piper Sandler also maintained a Buy rating on the stock with a $32.00 price target.
